These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17637939)

  • 21. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry.
    García M; Schneider DJ
    Pathophysiol Haemost Thromb; 2008; 36(2):75-9. PubMed ID: 19127086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiaggregant drugs: their pharmacology, mechanism of action and the interpretation of large trials].
    Cattaneo M; Mannucci PM
    G Ital Cardiol; 1990 Jul; 20(7):661-9. PubMed ID: 2147159
    [No Abstract]   [Full Text] [Related]  

  • 24. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel therapeutic targets at the platelet vascular interface.
    Brass LF; Zhu L; Stalker TJ
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s43-50. PubMed ID: 18174448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 27. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
    Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
    Lordkipanidzé M; Pharand C; Nguyen TA; Schampaert E; Diodati JG
    Ther Drug Monit; 2008 Jun; 30(3):372-8. PubMed ID: 18520610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.
    Raju NC; Eikelboom JW; Hirsh J
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):766-80. PubMed ID: 18957959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men.
    Hjorth Madsen E; Christiansen MK; Schmidt EB; Poulsen TS; Kristensen SR
    Platelets; 2009 May; 20(3):177-82. PubMed ID: 19437335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA; Mikhailidis DP
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
    Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J
    Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy.
    Grove EL; Hvas AM; Kristensen SD
    Kardiol Pol; 2008 Apr; 66(4):478-9. PubMed ID: 19496276
    [No Abstract]   [Full Text] [Related]  

  • 35. Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis.
    Borgwardt K; Bonifatius S; Gardemann A
    Nutr Res; 2008 Aug; 28(8):523-31. PubMed ID: 19083455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease-activated receptors in cardiovascular health and diseases.
    Shah R
    Am Heart J; 2009 Feb; 157(2):253-62. PubMed ID: 19185631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society.
    Kuliczkowski W; Witkowski A; Watala C; Filipiak KJ; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Polonski L;
    Kardiol Pol; 2008 Apr; 66(4):470-6, 480-5. PubMed ID: 18473281
    [No Abstract]   [Full Text] [Related]  

  • 39. The ultimate solution to the problem of aspirin resistance.
    Kottke BA
    J Am Coll Cardiol; 2008 Oct; 52(15):1276; author reply 1277. PubMed ID: 18926334
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of eptifibatide on inflammation during acute pain episodes in sickle cell disease.
    Brittain JE; Anea C; Desai P; Delaney J; McDonald A; Looney SW; Key NS; Parise LV; Ataga KI
    Am J Hematol; 2018 Aug; 93(4):E99-E101. PubMed ID: 29322543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.